Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Neuro-Oncology | August 21, 2017 | Volume: 20 | Issue: 4 | Pages: 546-556
10.1093/neuonc/nox161
| PMID 29016887